Replies to post #198797 on Avid Bioservices Inc (CDMO)

[cheynew]

Our team is showing little interest in ever resolving either suit.

[edcpf]

I'm not a lawyer but. From Peregrine's perspective, if the Phase III preliminary results are good, then there's certainly more weight in the argument that CSM delayed the treatment to Phase III and market by x months. From CSM's perspective, they could wager on the results being bad, in that case they could lose less. By some estimates, June could be around the time of the first look-in.

[Protector]

bio, I am sure this delay has NOTHING to do with some Science results of PPHM's clinical trials.

There may have been an unexpected development :)